Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole pretreatment plus conventional gonadotropin for ovulation induction in older women or women with diminished ovarian reserve undergoing ART
ChiCTR2000029272Phase 4Recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of letrozole in Diminished Ovarian Reserve (DOR) and Age-related infertility (2 arms), sponsored by Sun Yat-sen University. Primary endpoint: Cumulative clinical pregnancy rate of one controlled ovarian stimulation cycle. Started Mar 2020; status: recruiting.
02
Drugs
letrozole
03
Conditions
Diminished Ovarian Reserve (DOR)Age-related infertility
Beyond the preview
Go deeper on ChiCTR2000029272.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029272.